KODIAK SCIENCES INC. Debt Securities, Available-for-sale, Noncurrent
KODIAK SCIENCES INC. (KOD) had Debt Securities, Available-for-sale, Noncurrent of $8.53 million as of 2020-03-31, per its 10-Q filed 2020-05-11.
Discontinued › Balance Sheet › Assets › Long-Term Investments
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2021-03-01
- 2020-03-31: Debt Securities, Available-for-sale, Noncurrent $8.53M.
- 2019-12-31: Debt Securities, Available-for-sale, Noncurrent $11.70M.
| Period end | Debt Securities, Available-for-sale, Noncurrent |
|---|---|
| 2020-03-31 | $8.53M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $11.70M 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |